Gedeon Richter PLC (RGEDF)

Market Cap	7.52B +41.9%
Revenue (ttm)	2.76B +5.4%
Net Income	685.55M -4.1%
EPS	3.75 -4.0%
Shares Out	n/a
PE Ratio	10.96
Forward PE	8.17
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9
Open	43.62
Previous Close	41.33
Day's Range	41.79 - 43.62
52-Week Range	29.00 - 45.28
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About Gedeon Richter

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as we...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 11,155
• Stock Exchange: OTCMKTS
• Ticker Symbol: RGEDF

Financial Performance

In 2025, Gedeon Richter's revenue was 928.96 billion, an increase of 8.33% compared to the previous year's 857.55 billion. Earnings were 232.34 billion, a decrease of -2.89%.

Financial numbers in HUF